Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kunzea oil versus salicylic acid/LCD topical treatment for mild to moderate psoriasis
ACTRN12614001014640Phase 2Completed
- Sponsor
- University of Tasmania
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Salvax and coal tar solution in psoriasis (2 arms), sponsored by University of Tasmania. Primary endpoint: Change in Psoriasis Area and Severity Index. Started Aug 2007; status: completed.
02
Drugs
Salvaxcoal tar solution
03
Conditions
psoriasis
Beyond the preview
Go deeper on ACTRN12614001014640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001014640.